Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW
13,970
0.00 (0.00%)
At close: Feb 19, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Finished Product Business | 44.38B | 48.60B | 44.73B | 40.35B | 38.31B | | | | | |
Finished Product Business Growth | -8.68% | 8.66% | 10.84% | 5.32% | -3.64% | | | | | |
Raw Material Business Division | 5.53B | 5.18B | 5.80B | 6.52B | 7.27B | | | | | |
Raw Material Business Division Growth | 6.66% | -10.58% | -11.10% | -10.29% | 17.29% | | | | | |
| 49.91B | 53.79B | 50.53B | 46.87B | 45.58B | | | | | |
| -7.20% | 6.46% | 7.79% | 2.83% | -0.82% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 23.17B | 27.85B | 27.19B | 29.68B | 27.76B | | | | | |
| -16.80% | 2.42% | -8.38% | 6.91% | 6.20% | | | | | |
| 15.80B | 15.93B | 12.98B | 9.41B | 9.74B | | | | | |
| -0.82% | 22.75% | 37.88% | -3.31% | 10.86% | | | | | |
| 10.94B | 10.00B | 10.35B | 7.78B | 8.09B | | | | | |
| 9.34% | -3.37% | 33.06% | -3.77% | -26.75% | | | | | |
| 49.91B | 53.79B | 50.53B | 46.87B | 45.58B | | | | | |
| -7.20% | 6.46% | 7.79% | 2.83% | -0.82% | | | | | |
Source: S&P Global Market Intelligence.